Clinical trial
Therapeutic Zinc in Infant Bacterial Illness
NCT00347386 · Centre For International Health, Other · Completed
Key facts
| NCT number | NCT00347386 |
|---|---|
| Title | Therapeutic Zinc in Infant Bacterial Illness |
| Official title | Zinc as an Immunomodulator in the Treatment of Possible Serious Bacterial Infections in Infants 7 Days and up to 4 Months of Age |
| Lead sponsor | Centre For International Health, Other |
| Collaborators | All India Institute of Medical Sciences |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Sepsis, Bacterial Infections, Pneumonia |
| Intervention type | Drug |
| Interventions | Drug: Zinc (zinc sulphate), Placebo |
| Enrollment | 700 |
| Start date | Jul 1, 2005 |
| Primary completion | Dec 1, 2008 |
| Completion | Dec 1, 2008 |
| First posted | Jul 4, 2006 |
| Last update posted | Dec 7, 2010 |
| Countries | India |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: